The Factor V Leiden and Prothrombin G20210A Mutations in Kirghiz Population

• References

• 1 Rees DC. The population genetics of factor V Leiden (Arg 506 Gln). Br J Haematol 1996; 95: 579-86.
• 2 Rees DC, Chapman NH, Webster MT, Guerreiro JF, Rochette J, Clegg JB. Born to clot: the European burden. Br J Haematol 1999; 105: 564-6.
• 3 Gurgey A, Rustemov R, Parlak H, Balta G. Prevalence of factor V Leiden and Methylenetetrahydrofolate Reductase C677T mutations in Azerbaijan. Thromb Haemost 1998; 80: 520-1.
• 4 Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirnen RJ, de Ronde H, Van Der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
• 5 Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombine gene is associated with elevated plasma prothrombine levels and an increase in venouse thrombosis. Blood 1996; 88: 3698-703.
• 6 Togrul J, Rustemov R, Gurgey A, Altay S, Altay C. Prevalence of the prothrombin gene G20210A mutation in Azerbaijan. Br J Haemotol. (In press).
• 7 Gurgey A, Mesci L. The prevalence of factor V Leiden (1691 G-A) mutation in Turkey. Turk J Pediatr 1997; 39: 313-5.
• 8 Gurgey A, Hicsonmez G, Parlak H, Balta G, Celiker A. The prothrombin gene 20210 G-A mutation in Turkish patients with thrombosis. Am J Hema tol 1999; 59: 179-80.
• 9 Rosen E, Renbaum P, Heyd J, Levy-Lahad E. High frequency of factor V Leiden in a population of Israeli Arabs. Thromb Haemost 1999; 82: 1768.